As America strengthens its defenses at home and abroad, one company is helping secure the skies.
This NASDAQ-listed UAV company has become a trusted partner in both military and homeland security operations, advancing drone technology built to protect U.S. forces and fortify the nation's borders.
With its Flex FPV Modular Drones, the company is supporting U.S. Army programs that train soldiers to assemble, fly, and sustain FPV systems designed for rapid deployment and tactical response.
And with Outrider, it's bringing those same capabilities to the homeland - introducing a multi-mission border UAV built for long-endurance surveillance and real-time intelligence across the Southern Border's most challenging terrain.
From battlefield logistics to border overwatch, it's NDAA-compliant systems deliver secure, adaptable aerial solutions when visibility, speed, and reliability matter most.
With more than 25 years of mission-ready innovation, this company continues to set the standard for trusted drone technology in defense and public safety.
How this DoD-trusted drone manufacturer is helping secure America's skies.
Tomorrow Investor
The 3 Penny Stocks You Swore You'd Never Buy (But You'll Check Anyway)
By Chris Markoch. Article Posted: 1/18/2026.
Key Takeaways
- Vaxart is a clinical-stage biotech developing oral vaccines that could transform global immunization if its platform proves effective.
- Microvision develops cost-effective lidar technology for autonomous vehicles, with upside tied to industry adoption and potential partnerships.
- Datavault AI focuses on monetizing digital data through AI and blockchain tools, offering speculative exposure to the emerging data-as-an-asset theme.
Penny stocks attract speculative investors seeking high-risk, high-reward opportunities. That often means targeting companies with disruptive technologies, those participating in an emerging trend, or firms with compelling turnaround stories. Many of these companies will never survive or scale, but if even one succeeds, investors can realize impressive returns.
For investors who believe strength lies in numbers, MarketBeat offers a tool that lists the 100 Most Popular Penny Stocks. It's based on the number of MarketBeat subscribers following each company. While that's no guarantee of success, it can give an investor additional conviction in a stock's potential.
The retirement risk no one explained to you (Ad)
For years, Americans were told to keep money in the market and ride out volatility. That advice worked until it didn't. Central banks are now buying gold at record levels while governments quietly prepare for a new monetary framework. Your retirement account is likely exposed to risks you can't control: inflation eating away purchasing power, market swings erasing years of gains, and a weakening dollar. A growing number of Americans are moving part of their retirement savings into physical gold, real tangible assets held outside the traditional financial system.
Get the free guide explaining how a Gold IRA works and whether it makes sense for you.Some investors define a penny stock as any share trading for $5 or less. However, the stocks covered by this screener fall under the traditional definition: stocks priced below $1. These names are highly volatile. Do your own research and assess your risk tolerance before opening a position.
Vaxart: A Potential Game-Changer for Global Immunization Efforts
Vaxart Inc. (NASDAQ: VXRT) is a clinical-stage biotechnology company developing oral vaccines for infectious diseases, including influenza, norovirus and COVID-19. Unlike traditional vaccines administered by injection, Vaxart's tablet-based platform aims to simplify distribution and improve global accessibility.
The bull case for Vaxart centers on its innovative approach. If the company can secure FDA approval and successfully scale manufacturing and distribution, its oral vaccines could reduce logistical barriers to mass immunization campaigns and lead to significant licensing partnerships. Positive clinical data or a commercial collaboration could materially shift sentiment and valuation, given the stock's current low base.
Clinical risk remains the primary challenge. Vaxart has not yet brought a product to market, and vaccine development is costly and unpredictable. Competition from established players with much larger R&D budgets also limits visibility. For now, Vaxart is more of a long-term speculative bet on platform validation than a near-term profit story.
The MarketBeat analyst ratings show only a single analyst covering the stock, which should give investors pause. VXRT also has only about 18% institutional ownership. On a brighter note, the stock has relatively low short interest (around 2%), which could temper some volatility.
Microvision: Developing Cost-Effective LiDAR Units For Autonomous Driving
Microvision Inc. (NASDAQ: MVIS) develops LiDAR (light detection and ranging) sensors used in autonomous vehicles, smart infrastructure and industrial sensing. The company's hardware and software solutions enable precise 3D mapping needed for self-driving and advanced driver-assistance systems (ADAS). Microvision focuses on compact, cost-effective LiDAR units that could appeal to automakers seeking scalable sensor solutions.
The bull case for Microvision rests on two factors: continued progress toward vehicle automation and potential partnerships with major automotive manufacturers. If the company can demonstrate performance or cost advantages, it could secure supply agreements or licensing deals that significantly improve revenue visibility. Microvision's technology could also find applications beyond vehicles — in robotics, logistics and smart-city projects — adding optionality to its growth story.
Despite the promise, Microvision faces stiff competition from LiDAR players such as Luminar (NASDAQ: LAZR), Innoviz (NASDAQ: INVZ) and Ouster (NYSE: OUST). The path to profitability is uncertain, and recurring delays in LiDAR commercial adoption continue to frustrate investors.
MVIS is covered by three analysts and carries a consensus price target of $2.50, roughly a 169% increase from its Jan. 15 closing price. However, like many speculative names, Microvision shows moderate institutional ownership (around 30%) and elevated short interest (about 21%). Investors should be prepared for significant volatility.
Datavault AI: Trying to Democratize Data Ownership
Datavault AI Inc. (NASDAQ: DVLT) operates at the intersection of artificial intelligence, data monetization and digital asset management. The company helps organizations turn raw data into tradable, revenue-generating assets through its patented Datavault platform. By combining AI, blockchain and analytics, Datavault AI aims to democratize data ownership and unlock monetization opportunities that traditional systems may overlook.
The bullish thesis for Datavault AI rests on its niche focus and potential scalability. As data becomes an increasingly valuable commodity, businesses — and potentially individuals — are seeking ways to safely monetize digital information. Datavault's platform could benefit from growing AI adoption and increased interest in data sovereignty. Early-stage traction or strategic partnerships could accelerate investor confidence.
That said, Datavault AI operates in a highly experimental space. The company's business model is still evolving, and its path to meaningful revenue growth remains unproven. Institutions own less than 1% of the stock, and short interest exceeds 16% as of this writing. Investors considering DVLT should view it as a long-term, speculative position based on belief in data-as-an-asset innovation rather than near-term earnings potential.
This email is a sponsored email provided by The Tomorrow Investor, a third-party advertiser of MarketBeat. Why was I sent this email content?.
If you need assistance with your newsletter, please email MarketBeat's South Dakota based support team at contact@marketbeat.com.
If you would no longer like to receive promotional emails from MarketBeat advertisers, you can unsubscribe or manage your mailing preferences here.
© 2006-2026 MarketBeat Media, LLC.
345 North Reid Place, Sixth Floor, Sioux Falls, South Dakota 57103-7078. United States of America..